Last edition
News about "BioNTech"
Pfizer Cuts Majority of Its BioNTech Stake in Strategic Realignment
After the sale, Pfizer now holds around 1.66 million American Depositary Shares, valued at roughly USD 163 million as of late September 2025.
BioNTech | 14/11/2025 | By Darshana
BioNTech and Duality Biologics reach major breakthrough in breast cancer trial
BioNTech and Duality Biologics have announced a significant advance in cancer drug development with the successful outcome of a Phase III trial for their investigational therapy BNT323, also known as trastuzumab pamirtecan.
BioNTech | 06/09/2025 | By Darshana | 168
Pfizer and BioNTech's Updated COVID-19 Vaccine Secures EMA Nod, Awaits Final EU Approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Pfizer- BioNTech's LP.8.1-adapted monovalent COVID-19 vaccine in the European Union.
BioNTech | 28/07/2025 | By Dineshwori | 163
BioNTech | 14/03/2023 | By Sudeep Soparkar | 713
BioNTech to invest $43 M in German facility for mRNA vaccine
With the facility, BioNTech is seeking more control over the supply chain
BioNTech | 04/02/2023 | By Sudeep Soparkar | 526
BioNTech | 15/11/2022 | By Sudeep Soparkar | 896
BioNTech 2nd phase of Covid 19 trials completed
The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to receive an approval in China, which has relied only on domestically-developed vaccine
BioNTech | 12/05/2022 | By Sudeep Soparkar | 675
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy